What is a reasonable interval for retinopathy screening in patients with diabetes?

Article Type
Changed
Tue, 05/03/2022 - 16:10
Display Headline
What is a reasonable interval for retinopathy screening in patients with diabetes?
PRACTICE RECOMMENDATIONS

Assuming that a given patient is reliable for follow-up and that a clinical system is in place to handle a more individualized screening protocol, the investigators suggest the following approach: 3-year intervals for patients with no retinopathy and no risk factors (risk factors being diabetes for longer than 20 years or use of insulin); annual screening for patients with no retinopathy and 1 or both risk factors or for patients with background retinopathy; and 4-month intervals for patients with mild preproliferative retinopathy.

These intervals provide at least a 95% probability of remaining free of sight-threatening diabetic retinopathy between screenings.

 
Article PDF
Author and Disclosure Information

Practice Recommendations from Key Studies

Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003; 361:195–200.

Seth Miller, MD
Erik J. Lindbloom, MD, MSPH
Department of Family and Community Medicine, University of Missouri–Columbia

lindbloome@health.missouri.edu

Issue
The Journal of Family Practice - 52(5)
Publications
Topics
Page Number
349-364
Sections
Author and Disclosure Information

Practice Recommendations from Key Studies

Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003; 361:195–200.

Seth Miller, MD
Erik J. Lindbloom, MD, MSPH
Department of Family and Community Medicine, University of Missouri–Columbia

lindbloome@health.missouri.edu

Author and Disclosure Information

Practice Recommendations from Key Studies

Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003; 361:195–200.

Seth Miller, MD
Erik J. Lindbloom, MD, MSPH
Department of Family and Community Medicine, University of Missouri–Columbia

lindbloome@health.missouri.edu

Article PDF
Article PDF
PRACTICE RECOMMENDATIONS

Assuming that a given patient is reliable for follow-up and that a clinical system is in place to handle a more individualized screening protocol, the investigators suggest the following approach: 3-year intervals for patients with no retinopathy and no risk factors (risk factors being diabetes for longer than 20 years or use of insulin); annual screening for patients with no retinopathy and 1 or both risk factors or for patients with background retinopathy; and 4-month intervals for patients with mild preproliferative retinopathy.

These intervals provide at least a 95% probability of remaining free of sight-threatening diabetic retinopathy between screenings.

 
PRACTICE RECOMMENDATIONS

Assuming that a given patient is reliable for follow-up and that a clinical system is in place to handle a more individualized screening protocol, the investigators suggest the following approach: 3-year intervals for patients with no retinopathy and no risk factors (risk factors being diabetes for longer than 20 years or use of insulin); annual screening for patients with no retinopathy and 1 or both risk factors or for patients with background retinopathy; and 4-month intervals for patients with mild preproliferative retinopathy.

These intervals provide at least a 95% probability of remaining free of sight-threatening diabetic retinopathy between screenings.

 
Issue
The Journal of Family Practice - 52(5)
Issue
The Journal of Family Practice - 52(5)
Page Number
349-364
Page Number
349-364
Publications
Publications
Topics
Article Type
Display Headline
What is a reasonable interval for retinopathy screening in patients with diabetes?
Display Headline
What is a reasonable interval for retinopathy screening in patients with diabetes?
Sections
Disallow All Ads
Article PDF Media